Similarly, there is evidence that pharmacological inhibition or genetic ablation of neural GSK3β activity rescued dendritic spine and behavioral abnormalities linked to disc1 mutation, and other forms of schizophrenia (Lee et al., 2011b; Lipina et al., 2011). Here, GSK3B is linked to schizophrenia.